The price of UiPath Inc. (NYSE: PATH) closed at 13.79 in the last session, down -1.78% from day before closing price of $14.04. In other words, the price has decreased by $-0.25 from its previous closing price. On the day, 6123082 shares were traded. PATH reached its highest trading level at $14.10 during the session, while it also had its lowest trading level at $13.64.
We take a closer look at PATH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 07, 2022, Downgraded its rating to Equal-Weight and sets its target price to $15 from $32 previously.
On September 07, 2022, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $40 to $14.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 12 when Gupta Ashim sold 10,000 shares for $15.00 per share. The transaction valued at 150,027 led to the insider holds 297,505 shares of the business.
Gupta Ashim sold 30,000 shares of PATH for $450,600 on Sep 12. The Chief Financial Officer now owns 1,347,266 shares after completing the transaction at $15.02 per share. On Sep 08, another insider, Gupta Ashim, who serves as the Chief Financial Officer of the company, sold 10,000 shares for $13.74 each. As a result, the insider received 137,432 and left with 307,505 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.21 while its Price-to-Book (P/B) ratio in mrq is 4.07.
Stock Price History:
Over the past 52 weeks, PATH has reached a high of $59.57, while it has fallen to a 52-week low of $12.21. The 50-Day Moving Average of the stock is 17.94, while the 200-Day Moving Average is calculated to be 25.72.
According to the various share statistics, PATH traded on average about 6.71M shares per day over the past 3-months and 13.47M shares per day over the past 10 days. A total of 546.06M shares are outstanding, with a floating share count of 414.90M. Insiders hold about 1.80% of the company’s shares, while institutions hold 58.00% stake in the company. Shares short for PATH as of Jul 14, 2022 were 19.25M with a Short Ratio of 3.17, compared to 16.86M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.53% and a Short% of Float of 5.17%.
The company has 20 analysts who recommend its stock at the moment. On average, analysts expect EPS of $-0.11 for the current quarter, with a high estimate of $-0.07 and a low estimate of $-0.13, while EPS last year was $0.01. The consensus estimate for the next quarter is $0.01, with high estimates of $0.04 and low estimates of $-0.02.
Analysts are recommending an EPS of between $0.04 and $-0.08 for the fiscal current year, implying an average EPS of $-0.02. EPS for the following year is $0.1, with 22 analysts recommending between $0.38 and $-0.04.
A total of 22 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.12B, while the lowest revenue estimate was $1.08B, resulting in an average revenue estimate of $1.09B. In the same quarter a year ago, actual revenue was $892.25M, up 22.00% from the average estimate. Based on 22 analysts’ estimates, the company’s revenue will be $1.39B in the next fiscal year. The high estimate is $1.61B and the low estimate is $1.29B. The average revenue growth estimate for next year is up 27.90% from the average revenue estimate for this year.